DENTSPLY SIRONA Inc. $XRAY Shares Bought by Villanova Investment Management Co LLC

Villanova Investment Management Co LLC raised its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 188.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 80,949 shares of the medical instruments supplier’s stock after acquiring an additional 52,909 shares during the quarter. Villanova Investment Management Co LLC’s holdings in DENTSPLY SIRONA were worth $1,285,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Trust Co. of Toledo NA OH purchased a new stake in shares of DENTSPLY SIRONA during the second quarter worth approximately $27,000. Parkside Financial Bank & Trust lifted its holdings in DENTSPLY SIRONA by 620.6% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,477 shares in the last quarter. Brooklyn Investment Group acquired a new stake in DENTSPLY SIRONA during the 1st quarter worth $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of DENTSPLY SIRONA during the first quarter worth $26,000. Finally, Caitong International Asset Management Co. Ltd raised its position in shares of DENTSPLY SIRONA by 8,003.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 2,241 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analysts Set New Price Targets

XRAY has been the topic of a number of recent research reports. Zacks Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th. JPMorgan Chase & Co. dropped their price target on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research report on Friday, November 7th. Barrington Research cut their price target on DENTSPLY SIRONA from $18.00 to $14.00 and set an “outperform” rating for the company in a report on Monday, November 10th. Mizuho set a $13.00 price objective on DENTSPLY SIRONA in a research note on Friday, November 7th. Finally, Wall Street Zen cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, October 18th. Two investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $16.08.

Get Our Latest Stock Analysis on DENTSPLY SIRONA

DENTSPLY SIRONA Trading Down 0.2%

Shares of DENTSPLY SIRONA stock opened at $11.25 on Monday. The stock has a 50 day moving average of $11.90 and a 200 day moving average of $13.90. The company has a debt-to-equity ratio of 1.36, a quick ratio of 0.99 and a current ratio of 1.47. The firm has a market capitalization of $2.24 billion, a price-to-earnings ratio of -2.55, a PEG ratio of 0.82 and a beta of 1.01. DENTSPLY SIRONA Inc. has a fifty-two week low of $9.85 and a fifty-two week high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last announced its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.08). The business had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.33 million. DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. The business’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same period last year, the company earned $0.50 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. As a group, research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

See Also

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.